Ludovic Helfgott/LinkedIn
Mar 11, 2026, 14:54
Ludovic Helfgott: Grateful for Generosity in Supporting Patients with Hemophilia and Hemoglobinopathies
Ludovic Helfgott, Executive Vice President, Product and Portfolio Strategy at Novo Nordisk, shared a post on LinkedIn:
“One of the most gratifying things in the life of a Chairman of a not-for-profit organization is to take money directly from the pockets of your great colleagues and friends …for a good cause …and still see them smile afterwards.
Thanks to Maziar Mike Doustdar, Martin Holst Lange, Kasper Bødker Mejlvang, Habib Bennaceur (and many others) for your wonderful generosity in helping patients with hemophilia, hemoglobinopathies or diabetes around the world.”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 05:12Douglas S. Campbell: Great to See a Strong Japanese Presence in 2026 Lasker Awards
-
Sep 10, 2026, 05:11Jan Hartmann: New Transformative Treatment for Hemophilia A
-
Sep 10, 2026, 05:09Shelby Bradford: Award-Winning Science Incoming
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH